Skip to main content
CRSP
NASDAQ Life Sciences

CRISPR Therapeutics Secures $600M in Convertible Notes, Extends Cash Runway to 24+ Months

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$53.039
Mkt Cap
$5.167B
52W Low
$33.03
52W High
$78.48
52W Position info
61% above low
Off High info
32% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CRSP sits 61% above its 52-week low of $33.03.

Summary

CRISPR Therapeutics AG reported a reduced net loss for Q1 2026 and significantly boosted its liquidity by issuing $600 million in convertible senior notes, extending its cash runway to at least 24 months.


Key Events · Financing and Capital Events · CRSP

  • Successful Convertible Notes Offering

    The company issued $600 million in Convertible Senior Notes due 2031, resulting in net proceeds of $585.4 million. The initial conversion price is $76.56 per common share.

  • Extended Cash Runway

    Existing cash, cash equivalents, and marketable securities are expected to fund operating expenses and capital expenditures for at least the next 24 months.

  • Reduced Net Loss in Q1 2026

    Net loss for the three months ended March 31, 2026, improved to $122.9 million ($1.28 per share) from $136.0 million ($1.58 per share) in the same period last year.

  • Increased Liquidity

    Cash, cash equivalents, and marketable securities increased to $2.44 billion as of March 31, 2026, up from $1.99 billion at December 31, 2025.


Analysis · CRSP · Life Sciences

CRISPR Therapeutics AG reported a significant improvement in its financial position for the first quarter of 2026, primarily driven by a substantial capital raise. The company successfully issued $600 million in Convertible Senior Notes, providing $585.4 million in net proceeds, which has bolstered its cash reserves and extended its operational runway to at least 24 months. This financing is crucial for a biotech company with ongoing research and development activities. The initial conversion price of the notes is set at $76.56 per share, representing a premium to the current stock price, which could be viewed positively by investors as it suggests confidence in future valuation. Additionally, the company reported a reduced net loss compared to the prior year's quarter and was dismissed from a patent infringement lawsuit, further contributing to a positive outlook.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.3% of the 1982 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CRSP was trading at $53.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.2B. The 52-week trading range was $33.03 to $78.48. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CRSP - Latest Insights

CRSP
Nov 10, 2026, 1:48 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $45.48
Real-time Price: $42.52 info
Change: -$2.96 (-7%) info
Market Cap: $4.097B info
CRSP
Nov 09, 2026, 9:16 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $50.42
Real-time Price: $42.52 info
Change: -$7.90 (-16%) info
Market Cap: $4.097B info
CRSP
Nov 02, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $49.98
Real-time Price: $42.52 info
Change: -$7.46 (-15%) info
Market Cap: $4.097B info
CRSP
Nov 02, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $49.01
Real-time Price: $42.52 info
Change: -$6.49 (-13%) info
Market Cap: $4.097B info
CRSP
Nov 02, 2026, 4:06 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $49.01
Real-time Price: $42.52 info
Change: -$6.49 (-13%) info
Market Cap: $4.097B info